A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)
Clinical trial NCT06360354 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06360354
- Sponsor
- Amgen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-29
- Primary completion
- 2026-10-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.